title: Shared risk factors for anticoagulation in nonvalvular atrial fibrillation: a dilemma in clinical decision making.
authors.affiliation: Arrhythmia Service and Electrophysiology Fellowship Program, Alpert Medical School of Brown University, and Cardiovascular Institute, Rhode Island Miriam and Newport Hospitals, Providence, Rhode Island. Electronic address: mkim4@lifespan.org.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Kim
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011728:Pyridones / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin
keywords: atrial fibrillation; bleeding; factor Xa inhibitor